Viewing StudyNCT06066216



Ignite Creation Date: 2024-05-06 @ 7:34 PM
Last Modification Date: 2024-10-26 @ 3:10 PM
Study NCT ID: NCT06066216
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-01-23
First Post: 2023-09-27

Brief Title: Cadonilimab AK104 Plus Chemotherapy in Patients With Recurrent or Advanced Endometrial Cancer
Sponsor: Fujian Cancer Hospital
Organization: Fujian Cancer Hospital

Conditions & Keywords Data

Conditions:
Name
Endometrial Adenocarcinoma
Endometrial Cancer
Keywords:
Name View
Chemotherapy View
Endometrial Cancer View
Immune Checkpoint Inhibitors ICIs View
Anti-PD-1CTLA4 bi-specific antibody View
Antiangiogenic agents View